Cmbio®, is at the forefront of the human, animal, and planetary health—microbiome science. Formed from the unification of industry leaders like Clinical Microbiomics, CosmosID, MS-Omics, DNASense and Microba’s Research Services, Cmbio® stands as the first global microbiome service and technology company equipped with state-of-the-art multi-omics laboratories and advanced bioinformatics.
Our mission is to demystify the complex interplay of the microbiome and its vast influence on health and disease. By integrating applied AI with integrative systems biology, Cmbio® offers unparalleled insights and enterprise solutions that accelerate the pace of discovery and innovation in microbiome research.
With GxP-compliant facilities and a robust, scalable software platform, Cmbio® is uniquely positioned to standardize microbiome analysis, ensuring reliability and comparability across global studies. We are committed to advancing scientific understanding and enhancing well-being across all life on our planet.
Connect with Cmbio®: Explore how we're making strides in microbiome research and offering cutting-edge solutions to meet the grand challenges of health and sustainability.

Biotechnology

Health Diagnostics

Life Sciences

Cmbio

Anders Grøn

Nikolaj Sørensen

Manoj Dadlani

H. Bjørn Nielsen

Marianne Koliana

Caroline Popper M.d., Mph, J.d.

Nathan Ledeboer

Morten Sommer

Isabelle De Cremoux

Bruce Grant

Henrik Bjørn Nielsen

Cmbio

Org chart

Similar companies